MarketPeel
EVP, General Counsel
Thu, Jun 25, 2026
Jun 25
sold $347.27k of KRYS
1,000 shares @ $347.27
Decreased holdings by -100.00%
Largest trade (out of 4)
Planned (10b5-1)
The acquisition and sale of shares of the Company's common stock reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 23, 2026. All transactions contemplated by the plan have been completed, and the plan has terminated in accordance with its terms.Form 4 footnote
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Price 45% above 200-day moving average
KRYSKrystal Biotech, Inc.
HealthcareBiotechnology
1D0.00%
1W+4.31%
1M+3.40%
3M
6M
1Y

Recent insider activity at KRYS

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback